SARS-CoV-2: clinical or host-associated
BioSampleModel
2023-06-23T02:11:48Z
ENA-FIRST-PUBLIC
2023-06-23T02:11:48Z
ENA-LAST-UPDATE
SAMN35841478
External Id
NYGC
INSDC center name
2023-06-23T02:11:48Z
INSDC first public
2023-06-23T02:11:48Z
INSDC last update
public
INSDC status
SRS18040125
SRA accession
38537-21-2-9584204
Submitter Id
PRJNA766678
bioproject_accession
NCBI
broker name
Universidad Autonoma de Yucatan
collected_by
2021-09-25
collection_date
Mexico: Yucatan, Chemax, Miraflores
geo_loc_name
EPI_ISL_13136721
gisaid_accession
hCoV-19/Mexico/YUC-NYGC-38537-21/2021
gisaid_virus_name
Homo sapiens
host
38
host_age
COVID-19
host_disease
male
host_sex
NP
host_subject_id
SARS-CoV-2/Human/Mexico/YUC-NYGC-38537-21/2021
isolate
clinical
isolation_source
Severe acute respiratory syndrome coronavirus 2
organism
Severe acute respiratory syndrome coronavirus 2
organism
38537-21
sample_name
19
sars_cov_2_diag_pcr_ct_value_1
Severe acute respiratory syndrome coronavirus 2
scientific_name
New York Genome Center
sequenced_by
SARS-CoV-2: Clinical Severe acute respiratory syndrome coronavirus 2 sample collected from NYC metropolitan area
title
PFIZER BIONTECH
vaccine_received